Dr. Robert Adam Graham , MD
Physician • Fresno, CA
728 E Bullard Ave Ste 101
Fresno, CA 937105474
Phone: 5594323040
Location details and other listingsThis profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
This NPI Is Deactivated in NPPES
NPPES lists this NPI as deactivated as of November 22, 2023; the reason is not published. The records below are historical. They do not show whether Dr. Robert Graham currently practices or holds a license; check the state medical board for current license status.
-
NPI assigned on March 2, 2007; this date does not establish years in practice.
-
Published CMS data list 218 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 99213 — Established patient outpatient office visit: 158 service units.
- 99214 — Established patient outpatient office visit: 60 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 2,437 Medicare Part D prescriptions, including refills, in 2023.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Published rows only; this is not a quality measure.
-
Published Part D records, 2023:
- Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) — 356 prescription fills, including refills.
- Alprazolam — 162 prescription fills, including refills.
- Levothyroxine Sodium — 108 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 58 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 6,978 in 2019 to 218 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
728 E Bullard Ave Ste 101
Fresno, CA 937105474
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Physician: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $20,090 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $11,814 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
3,659 standardized 30-day fills in 2023
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$120,653 in 2023
The total cost of these prescriptions in 2023, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2023.
Open Payments general payments, program year 2023
All general payments: $159.64 across 8 records.
By nature of payment
- Food and Beverage: $159.64 across 8 records.
Reporting-company totals (3 largest of 6)
- ITI, Inc.: $55.09 across 3 records.
- Axsome Therapeutics, Inc.: $31.72 across 1 record.
- Novo Nordisk Inc: $22.42 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2023 (published June 30, 2026).
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Compared with the same specialty in Fresno and California
Comparisons are not shown because NPPES lists this NPI as deactivated.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 97% from 6,978 in 2019 to 218 in 2023.
- 2019: 6,978
- 2020: 644
- 2021: 671
- 2022: 394
- 2023: 218
-
Medicare-allowed amount
Medicare-allowed amount decreased 91% from $227,617 in 2019 to $20,090 in 2023.
- 2019: $227,617
- 2020: $53,016
- 2021: $58,668
- 2022: $35,417
- 2023: $20,090
-
Paid by Medicare
Paid by Medicare decreased 93% from $160,347 in 2019 to $11,814 in 2023.
- 2019: $160,347
- 2020: $31,694
- 2021: $38,447
- 2022: $22,783
- 2023: $11,814
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 18% from 2,981 in 2019 to 2,437 in 2023.
- 2019: 2,981
- 2020: 2,929
- 2021: 3,059
- 2022: 3,311
- 2023: 2,437
-
30-day fills
30-day fills decreased 18% from 4,451 in 2019 to 3,659 in 2023.
- 2019: 4,451
- 2020: 4,492
- 2021: 4,565
- 2022: 4,855
- 2023: 3,659
-
Part D drug cost
Part D drug cost decreased 19% from $148,418 in 2019 to $120,653 in 2023.
- 2019: $148,418
- 2020: $137,546
- 2021: $144,482
- 2022: $204,045
- 2023: $120,653
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $875.54 in 2019 to $159.64 in 2023.
- 2019: $875.54
- 2020: $1,173.02
- 2021: $881.85
- 2022: $587.28
- 2023: $159.64
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2023), CMS Open Payments (2023), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2023 (payments made January 1 – December 31, 2023): fewer than 11 records totaling $159.64.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Axsome Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
Auvelity | General | $31.72 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Wegovy | General | $22.42 |
| Exact Sciences Corporation |
Food and Beverage
In-kind items and services
|
Cologuard Collection Kit | General | $21.45 |
| ITI, Inc. |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $21.02 |
| ITI, Inc. |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $18.25 |
| ITI, Inc. |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $15.82 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $15.81 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
— | General | $13.15 |
Source: CMS Open Payments, program year 2023, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
158 | 94 | $85.00 | $83.94 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
60 | 53 | $115.00 | $113.79 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2023.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 356 | 10,397 | $12,308.25 | 65 |
| Alprazolam | Alprazolam | 162 | 4,786 | $1,144.53 | 28 |
| Levothyroxine Sodium | Levothyroxine Sodium | 108 | 9,210 | $2,376.93 | 38 |
| Hydrocortisone | Hydrocortisone | 103 | 4,122 | $3,061.57 | 42 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 78 | 1,647 | $2,231.30 | 49 |
| Diazepam | Diazepam | 73 | 2,090 | $420.33 | 15 |
| Lorazepam | Lorazepam | 69 | 2,218 | $973.79 | 14 |
| Amlodipine Besylate | Amlodipine Besylate | 68 | 4,560 | $672.64 | 23 |
| Lisinopril | Lisinopril | 66 | 5,280 | $807.51 | 22 |
| Jardiance | Empagliflozin | 64 | 3,120 | $64,154.94 | 16 |
| Oxycodone Hcl | Oxycodone Hcl | 63 | 1,829 | $2,307.85 | — |
| Ibuprofen | Ibuprofen | 56 | 1,831 | $488.03 | 14 |
| Gabapentin | Gabapentin | 54 | 1,865 | $1,102.18 | 11 |
| Furosemide | Furosemide | 49 | 2,730 | $256.43 | 20 |
| Omeprazole | Omeprazole | 46 | 3,030 | $542.55 | 19 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 45 | 1,193 | $1,549.38 | — |
| Metformin Hcl | Metformin Hcl | 42 | 2,940 | $541.09 | 12 |
| Testosterone Cypionate | Testosterone Cypionate | 39 | 2,814 | $3,454.55 | 17 |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 945 | $1,482.86 | 14 |
| Carvedilol | Carvedilol | 36 | 1,800 | $526.15 | — |
| Losartan Potassium | Losartan Potassium | 36 | 2,760 | $560.72 | 12 |
| Tramadol Hcl | Tramadol Hcl | 35 | 981 | $965.57 | — |
| Carisoprodol | Carisoprodol | 35 | 988 | $508.71 | — |
| Tamsulosin Hcl | Tamsulosin Hcl | 34 | 2,760 | $965.13 | 12 |
| Estradiol | Estradiol | 31 | 2,190 | $552.49 | 12 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2023; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 261QP2300X
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPPES lists this NPI as deactivated as of November 22, 2023; the reason is not published.
NPI status registered as active in NPPES database
Registered at 728 E BULLARD AVE STE 101, FRESNO, CA 937105474 (Tel: 5594323040)
Registered at 728 E BULLARD AVE STE 101, FRESNO, CA 937105474 (Tel: 5594323040)
Recorded as ROBERT GRAHAM, M.D.
Clinic/Center (license number reported to NPPES: CA A32806)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Mailing Address
728 E Bullard Ave Ste 101
Fresno, CA 937105474
Phone: 5594323040